Abstract P5-02-10: Overexpression of Indoleamine 2,3-dioxygenase 1 in HER2 positive breast cancer correlates with increase of tumor-infiltrating lymphocytes level and worse overall survival

Her2 Positive ◽

Indoleamine 2,3 Dioxygenase ◽

Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy

Breast Cancer Research and Treatment ◽

10.1007/s10549-015-3617-7 ◽

2015 ◽

Vol 154 (2) ◽

pp. 239-249 ◽

Cited By ~ 13

Author(s):

Shiwei Liu ◽

Xuening Duan ◽

Ling Xu ◽

Ling Xin ◽

Yuanjia Cheng ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Prognostic Value ◽

Optimal Threshold ◽

Her2 Positive ◽

Predictive And Prognostic Value ◽

FcrR3A-158 Polymorphism and Stromal Tumor-Infiltrating Lymphocytes and Survival among Patients with Metastatic HER2-Positive Breast Cancer Receiving Trastuzumab-Based Treatment

Journal of Breast Cancer ◽

10.4048/jbc.2018.21.1.45 ◽

2018 ◽

Vol 21 (1) ◽

pp. 45

Author(s):

Heejung Chae ◽

Changhoon Yoo ◽

Jung-A Yoon ◽

Hee Jin Lee ◽

Kyu-pyo Kim ◽

...

Keyword(s):

Breast Cancer ◽

Stromal Tumor ◽

Her2 Positive ◽

Abstract P6-09-07: Mutation characteristics and tumor infiltrating lymphocytes in early and metastatic HER2-positive breast cancer

10.1158/1538-7445.sabcs16-p6-09-07 ◽

2017 ◽

Author(s):

V Kotoula ◽

E Giannoulatou ◽

G Kouvatseas ◽

I Tikas ◽

G Lazaridis ◽

...

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Abstract P4-14-17: Prognostic value of tumor-infiltrating lymphocytes in residual tumors after neoadjuvant chemotherapy concomitant with trastuzumab for HER2-positive breast cancer

10.1158/1538-7445.sabcs15-p4-14-17 ◽

2016 ◽

Author(s):

S Kurozumi ◽

K Inoue ◽

H Matsumoto ◽

Y Hayashi ◽

K Tozuka ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Prognostic Value ◽

Her2 Positive ◽

Tumor infiltrating lymphocytes as a predictive factor in Pertuzumab/Trastuzumab-treated HER2-positive breast cancer

Annals of Oncology ◽

10.1093/annonc/mdx621.041 ◽

2017 ◽

Vol 28 ◽

pp. ix104

Author(s):

Kanako Saito ◽

Yuji Kotsuka ◽

Hiroyasu Oda ◽

Mikiya Ishihara ◽

Satoshi Tamaru ◽

...

Keyword(s):

Breast Cancer ◽

Predictive Factor ◽

Her2 Positive ◽

Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05819-8 ◽

2020 ◽

Vol 183 (3) ◽

pp. 599-606

Author(s):

Jing Zhao ◽

Jane Meisel ◽

Yi Guo ◽

Rita Nahta ◽

Kung Lin Hsieh ◽

...

Keyword(s):

Breast Cancer ◽

Immune Cells ◽

Her2 Positive ◽

Prognostic Implication of Tumor-Infiltrating Lymphocytes in Patients With HER2-Positive Breast Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.118 ◽

2016 ◽

Vol 96 (2) ◽

pp. S44-S45

Author(s):

E.J. Yoshida ◽

Q. Li ◽

A. Chung ◽

B. Knudsen ◽

M. Burnison ◽

...

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Prognostic Implication ◽

Effect of tumor infiltrating lymphocytes (TILs) and stromal CD68 on trastuzumab (T) benefit in early stage HER2 positive breast cancer (BC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.556 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 556-556

Author(s):

Jacques Raphael ◽

Inna Y Gong ◽

Sharon Nofech-Mozes ◽

John M. S. Bartlett ◽

Houman Nafisi ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Her2 Positive ◽

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-2338 ◽

2016 ◽

Vol 22 (23) ◽

pp. 5747-5754 ◽

Cited By ~ 69

Author(s):

Barbara Ingold Heppner ◽

Michael Untch ◽

Carsten Denkert ◽

Berit M. Pfitzner ◽

Bianca Lederer ◽

...

Keyword(s):

Breast Cancer ◽

Prognostic Biomarker ◽

Her2 Positive ◽

Predictive And Prognostic Biomarker ◽

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

BMC Cancer ◽

10.1186/s12885-016-2302-5 ◽

2016 ◽

Vol 16 (1) ◽

Cited By ~ 19

Author(s):

Alexander S. Brodsky ◽

Jinjun Xiong ◽

Dongfang Yang ◽

Christoph Schorl ◽

Mary Anne Fenton ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Therapy ◽

Predictive Markers ◽

Her2 Positive ◽

Estrogen Receptor Positive ◽